Results of a study explored the potential of automated lung tumor vascularity. A study assessed unmet needs as well as QOL and FT in survivors of NSCLC. A study assessed differences in lung cancer screening eligibility among lung cancer survivors. Depression is common in patients with lung cancer and those with type 2 diabetes. VOCs are known to be associated with lung cancer, and EGFR mutations are common in lung adenocarcinoma. Reduction of hemolysis significantly predicted postinfusion transduction efficacy in patients with SCD treated with lovo-cel. A study examined the impact of the Interception-Lung program, which aims to reduce the incidence of advanced lung cancer. A study evaluated the prognosis of patients with locally advanced and metastatic NSCLC who underwent prior TKI. The study aimed to investigate the relationship between tobacco use and lung cancer. The TROPION-Lung07 trial will evaluate Dato-DXd plus pembrolizumab in patients with advanced/metastatic NSCLC. HSCT with a matched unrelated or haploidentical donor was a promising alternative in patients with severe aplastic anemia. Ischemic stroke survivors who received care recommendations from an AI-based system had fewer secondary strokes. Stroke survivors living in areas with poor economic conditions are twice as likely to have poor recovery outcomes. Patients whose heads are positioned at a 0-degree angle prior to surgery have significantly improved neurological function. Individuals who suffer a stroke have a significantly increased risk of developing dementia. Black women who develop high blood pressure before the age of 35 may have triple the risk of stroke. In patients with HCC, a high CD8 and low TIM3 expression is linked to better OS than PD-1/PD-L1. Meta-analysis data has shown that HAIP combined with systemic chemotherapy can provide a pooled 3-year OS rate of 39.5%. A study analyzed the clinicopathological characteristics of small-scale ROS1 mutations in patients with NSCLC. A study looked at the modulating effects of neoadjuvant immunotherapy and CRT on TDLN in patients with T2-4NO-1 NSCLC.